OrstavikK.H.. Skewed X inactivation in healthy individuals and in different diseases.Acta Paediatr Suppl2006; 695: 24–9.
2.
BullerR.E., SoodA.K., LallasT., BuekersT., SkillingJ.S.. Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.J Natl Cancer Inst1999; 91: 339–46.
3.
KristiansenM., LangerødA., KnudsenG.P., WeberB.L., Børresen-DaleA.L., OrstavikK.H.. High frequency of skewed X inactivation in young breast cancer patients.J Med Genet2002; 39: 30–3.
4.
KristiansenM., KnudsenG.P., MaguireP.. High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer.J Med Genet2005; 42: 877–80.
5.
StruewingJ.P., PinedaM.A., ShermanM.E.. Skewed X chromosome inactivation and early-onset breast cancer.J Med Genet2006; 43: 48–53.
6.
LiG., SuQ., LiuG.Q.. Skewed X chromosome inactivation of blood cells is associated with early development of lung cancer in females.Oncol Rep2006; 16: 859–64.
7.
AllenR.C., ZoghbiH.Y., MoseleyA.B., RosenblattH.M., BelmontJ.W.. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation.Am J Hum Genet1992; 51: 1229–39.